NOVARTIS PHARMA AG enters CELLULAR BIOMEDICINE GROUP, INC. with 1.46M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 8/14/2020ACC: 0001104659-20-095585
10% Owner
Since Aug 2020
1.46M
Baseline shares
100% direct
1.46M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.46M
Total
1.46M direct1.46M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.46M | Direct |
| Total | 1.46M | 1.46M direct |
Derivative Holdings0
No derivative holdings reported